|
Q4 FY2026
As of Sep 3, 2026
|
Q3 FY2026
As of May 28, 2026
|
Q2 FY2026
As of Feb 26, 2026
|
Q1 FY2026
As of Nov 27, 2025
|
Q4 FY2025
As of Aug 28, 2025
|
Q3 FY2025
As of May 29, 2025
|
Q2 FY2025
As of Feb 27, 2025
|
Q1 FY2025
As of Nov 28, 2024
|
Q4 FY2024
As of Aug 29, 2024
|
Q3 FY2024
As of May 30, 2024
|
Q2 FY2024
As of Feb 29, 2024
|
Q1 FY2024
As of Nov 30, 2023
|
Q4 FY2023
As of Aug 31, 2023
|
Q3 FY2023
As of Jun 1, 2023
|
Q2 FY2023
As of Mar 2, 2023
|
Q1 FY2023
As of Dec 1, 2022
|
Q4 FY2022
As of Sep 1, 2022
|
Q3 FY2022
As of Jun 2, 2022
|
Q2 FY2022
As of Mar 3, 2022
|
Q1 FY2022
As of Dec 2, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Receivables | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Long-term marketable investments | ||||||||||||||||||||
| Property, plant, and equipment | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and equity | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Current debt | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Noncurrent operating lease liabilities | ||||||||||||||||||||
| Noncurrent unearned government incentives | ||||||||||||||||||||
| Noncurrent customer contract liabilities | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common Stock, outstanding (in shares) | ||||||||||||||||||||
| Common Stock, par value (in dollars per share) | ||||||||||||||||||||
| Common Stock, authorized shares (in shares) | ||||||||||||||||||||
| Common Stock, issued (in shares) | ||||||||||||||||||||
| Shareholders’ equity | ||||||||||||||||||||
| Common stock, $0.10 par value, 3,000 shares authorized, 1,277 shares issued and 1,131 outstanding (1,266 shares issued and 1,122 outstanding as of August 28, 2025) | ||||||||||||||||||||
| Additional capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, 146 shares held (144 shares as of August 28, 2025) | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
